+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Divalproex Sodium Global Market Report 2025

  • PDF Icon

    Report

  • 175 Pages
  • January 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103900
The divalproex sodium market size has grown strongly in recent years. It will grow from $1.83 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth observed during the historical period can be credited to several factors, including increased healthcare spending, the expansion of pharmaceutical distribution networks, a rising demand for outpatient and home-based treatments, government reimbursement and insurance assistance, and a growing need for chronic disease management.

The divalproex sodium market size is expected to see strong growth in the next few years. It will grow to $2.6 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth anticipated during the forecast period can be attributed to the rising prevalence of epilepsy, the increasing incidence of bipolar disorder, higher diagnosis rates of migraine disorders, a growing elderly population susceptible to neurological conditions, and expanded access to healthcare. Key trends in this period include advancements in drug formulation methods, increased research on central nervous system (CNS) disorders, innovations in drug delivery systems, enhanced diagnostic tools for epilepsy and bipolar disorders, and the development of biomarkers for targeted treatments.

The increasing prevalence of neurological disorders is expected to drive the growth of the divalproex sodium market in the future. Neurological disorders are conditions that affect the brain, spinal cord, or nerves, leading to impairments in function and symptoms such as muscle weakness, seizures, or cognitive difficulties. As life expectancy rises, the aging population becomes more susceptible to conditions including Alzheimer’s and Parkinson’s, which tend to develop later in life. Divalproex sodium plays a crucial role in managing neurological disorders by stabilizing electrical activity in the brain, preventing seizures, and controlling mood swings, which are common in conditions including epilepsy and bipolar disorder. For example, data from the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that approximately 2.9 million U.S. adults aged 18 and older had active epilepsy in 2021 and 2022, accounting for about 1% of the adult population in the U.S. As the prevalence of neurological disorders rises, the demand for divalproex sodium is expected to grow.

Key players in the divalproex sodium market are concentrating on developing innovative solutions, such as extended-release tablets, to improve patient compliance. These tablets are designed to release their active ingredient gradually over time, enabling less frequent dosing and providing more consistent therapeutic effects. For example, in March 2022, Unichem Laboratories, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for its generic version of Divalproex Sodium extended-release tablets in 250 mg and 500 mg dosages. These tablets are used to treat acute manic or mixed episodes associated with bipolar disorder, both as a standalone treatment and in combination with other therapies, as well as for preventing migraine headaches.

In June 2024, Lotus Pharmaceuticals, a pharmaceutical company based in Taiwan, acquired the Thailand business and commercial operations of Teva Pharmaceuticals for an undisclosed amount. Following the acquisition, Lotus will assume responsibility for marketing and selling Teva Pharma Thailand's current product portfolio, which will become a wholly owned subsidiary of Teva. This acquisition will allow Lotus to expand its presence in Thailand by adding respiratory and ophthalmic products to its offerings and growing its local workforce to approximately 100 employees. The move will enhance Lotus's ability to reach more hospitals and pharmacies in the region. Teva Pharmaceuticals is an Israel-based manufacturer of divalproex sodium.

Major players in the divalproex sodium market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals Public Limited Company, Amneal Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Supernus Pharmaceuticals Inc., Strides Pharma Science Limited, Upsher-Smith Laboratories LLC, Ajanta Pharma Limited, Ishita Active Pharmaceutical Ingredients, Varahi International, Roaq Chemicals Private Limited, and MSN Laboratories Private Limited.

North America was the largest region in the divalproex sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in divalproex sodium report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the divalproex sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Divalproex sodium is a prescribed drug used to treat various neurological and psychiatric conditions. It is a combination of sodium valproate and valproic acid, which function by boosting the levels of gamma-aminobutyric acid (GABA) in the brain. GABA is a chemical that helps decrease excessive nerve activity. By stabilizing the brain's electrical signals, this medication promotes mental and neurological equilibrium.

Divalproex sodium is available in several forms, including tablets, capsules, extended-release tablets, and more. Tablets are solid oral dosage forms that contain the active ingredients, pressed into a specific shape for easy administration. It can be taken orally or intravenously and is used to treat conditions including epilepsy, bipolar disorder, migraine prevention, and neuropsychiatric disorders. The drug is available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels.

The divalproex sodium market research report is one of a series of new reports that provides divalproex sodium market statistics, including divalproex sodium industry global market size, regional shares, competitors with a divalproex sodium market share, divalproex sodium market segments, market trends and opportunities, and any further data you may need to thrive in the divalproex sodium. This divalproex sodium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The divalproex sodium market consists of sales of valproic acid oral solution, carbamazepine tablets, and lamotrigine tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Divalproex Sodium Market Characteristics3. Divalproex Sodium Market Trends And Strategies4. Divalproex Sodium Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Divalproex Sodium Growth Analysis And Strategic Analysis Framework
5.1. Global Divalproex Sodium PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Divalproex Sodium Market Growth Rate Analysis
5.4. Global Divalproex Sodium Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Divalproex Sodium Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Divalproex Sodium Total Addressable Market (TAM)
6. Divalproex Sodium Market Segmentation
6.1. Global Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • Extended-Release Tablets
  • Others Products
6.2. Global Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Intravenous
6.3. Global Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epilepsy Treatment
  • Bipolar Disorder Management
  • Migraine Prophylaxis
  • Neuropsychiatric Disorders
  • Other Applications
6.4. Global Divalproex Sodium Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distributions
6.5. Global Divalproex Sodium Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
250 Mg Tablets
500 Mg Tablets
  • Other Strength Tablets
6.6. Global Divalproex Sodium Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
125 Mg Capsules250 Mg Capsules
500 Mg Capsules
  • Other Strength Capsules
6.7. Global Divalproex Sodium Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
250 Mg Extended-Release Tablets
500 Mg Extended-Release Tablets
  • Other Strength Extended-Release Tablets
6.8. Global Divalproex Sodium Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Solution
  • Injectable Form
7. Divalproex Sodium Market Regional And Country Analysis
7.1. Global Divalproex Sodium Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Divalproex Sodium Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Divalproex Sodium Market
8.1. Asia-Pacific Divalproex Sodium Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Divalproex Sodium Market
9.1. China Divalproex Sodium Market Overview
9.2. China Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Divalproex Sodium Market
10.1. India Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Divalproex Sodium Market
11.1. Japan Divalproex Sodium Market Overview
11.2. Japan Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Divalproex Sodium Market
12.1. Australia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Divalproex Sodium Market
13.1. Indonesia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Divalproex Sodium Market
14.1. South Korea Divalproex Sodium Market Overview
14.2. South Korea Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Divalproex Sodium Market
15.1. Western Europe Divalproex Sodium Market Overview
15.2. Western Europe Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Divalproex Sodium Market
16.1. UK Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Divalproex Sodium Market
17.1. Germany Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Divalproex Sodium Market
18.1. France Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Divalproex Sodium Market
19.1. Italy Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Divalproex Sodium Market
20.1. Spain Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Divalproex Sodium Market
21.1. Eastern Europe Divalproex Sodium Market Overview
21.2. Eastern Europe Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Divalproex Sodium Market
22.1. Russia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Divalproex Sodium Market
23.1. North America Divalproex Sodium Market Overview
23.2. North America Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Divalproex Sodium Market
24.1. USA Divalproex Sodium Market Overview
24.2. USA Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Divalproex Sodium Market
25.1. Canada Divalproex Sodium Market Overview
25.2. Canada Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Divalproex Sodium Market
26.1. South America Divalproex Sodium Market Overview
26.2. South America Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Divalproex Sodium Market
27.1. Brazil Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Divalproex Sodium Market
28.1. Middle East Divalproex Sodium Market Overview
28.2. Middle East Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Divalproex Sodium Market
29.1. Africa Divalproex Sodium Market Overview
29.2. Africa Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Divalproex Sodium Market Competitive Landscape And Company Profiles
30.1. Divalproex Sodium Market Competitive Landscape
30.2. Divalproex Sodium Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
31. Divalproex Sodium Market Other Major And Innovative Companies
31.1. Bausch Health Companies Inc.
31.2. Aurobindo Pharma Limited
31.3. Hikma Pharmaceuticals Public Limited Company
31.4. Amneal Pharmaceuticals Inc.
31.5. Lupin Limited
31.6. Zydus Lifesciences Limited
31.7. Alkem Laboratories Limited
31.8. Alembic Pharmaceuticals Limited
31.9. Supernus Pharmaceuticals Inc.
31.10. Strides Pharma Science Limited
31.11. Upsher-Smith Laboratories LLC
31.12. Ajanta Pharma Limited
31.13. Ishita Active Pharmaceutical Ingredients
31.14. Varahi International
31.15. Roaq Chemicals Private Limited
32. Global Divalproex Sodium Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Divalproex Sodium Market34. Recent Developments In The Divalproex Sodium Market
35. Divalproex Sodium Market High Potential Countries, Segments and Strategies
35.1 Divalproex Sodium Market In 2029 - Countries Offering Most New Opportunities
35.2 Divalproex Sodium Market In 2029 - Segments Offering Most New Opportunities
35.3 Divalproex Sodium Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Divalproex Sodium Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on divalproex sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for divalproex sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The divalproex sodium market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product Type: Tablets; Capsules; Extended-Release Tablets; Others Products
2) By Route of Administration: Oral; Intravenous
3) By Application: Epilepsy Treatment; Bipolar Disorder Management; Migraine Prophylaxis; Neuropsychiatric Disorders; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distributions

Subsegments:

1) By Tablets: 250 Mg Tablets; 500 Mg Tablets; Other Strength Tablets
2) By Capsules: 125 Mg Capsules; 250 Mg Capsules; 500 Mg Capsules; Other Strength Capsules
3) By Extended-Release Tablets: 250 Mg Extended-Release Tablets; 500 Mg Extended-Release Tablets; Other Strength Extended-Release Tablets
4) By Other Products: Oral Solution; Injectable Form

Key Companies Profiled: AbbVie Inc.; Sanofi S.A.; Abbott Laboratories; Teva Pharmaceutical Industries Ltd.; Mylan N.V.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • AbbVie Inc.
  • Sanofi S.A.
  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Bausch Health Companies Inc.
  • Aurobindo Pharma Limited
  • Hikma Pharmaceuticals Public Limited Company
  • Amneal Pharmaceuticals Inc.
  • Lupin Limited
  • Zydus Lifesciences Limited
  • Alkem Laboratories Limited
  • Alembic Pharmaceuticals Limited
  • Supernus Pharmaceuticals Inc.
  • Strides Pharma Science Limited
  • Upsher-Smith Laboratories LLC
  • Ajanta Pharma Limited
  • Ishita Active Pharmaceutical Ingredients
  • Varahi International
  • Roaq Chemicals Private Limited
  • MSN Laboratories Private Limited.